The KRAS gene, a crucial component of cell signaling pathways involved in cell growth and division, is frequently mutated in various cancers. By targeting the gene, KRAS inhibitors aim to block the aberrant signaling that promotes cancer cell proliferation. Amgen's sotorasib became the first approved KRAS inhibitor, opening up an exciting field.
Accelerating Novel Therapies To The Market
The formulations for novel therapeutics require flexibility to support adaptive sterile manufacturing and an integrated approach for a path from development to small batch manufacturing, to commercialization.
Optimizing CDMO Technical Transfer
Learn in detail how a CDMO helps biopharma organizations predict and mediate technical transfer risks before they become costly, time-consuming problems.
Industry Trends: CDMO Outsourcing
No single CDMO strategy or outsourcing model is appropriate for every project. Outsourcers can and should evaluate a strategy and partner(s) on a case-by-case basis.
Pediatric Dosage Formulation
A biopharmaceutical company known for its successful anti-infective products for adults sought to reformulate the product into an age-appropriate dosage form for young children and preteen patients.
Get ready for the most anticipated event of 2023! Join us October 15-18 in Las Vegas, NV, for the 2023 ISPE Annual Meeting & Expo. Experience cutting-edge insights, networking opportunities, and the latest advancements in pharmaceutical engineering. Don't miss this chance to connect with industry leaders and shape the future of the pharmaceutical industry. Register today and be part of a transformative experience!
LIFE SCIENCE LEADER MAGAZINE
Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.
|Connect With Pharmaceutical Online:|